XML 27 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions (Tables)
12 Months Ended
Mar. 31, 2015
Insight Pharmaceuticals Corporation  
Business Acquisition [Line Items]  
Purchase Price Allocation
The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the September 3, 2014 acquisition date.

(In thousands)
September 3, 2014
 
 
Cash acquired
$
3,507

Accounts receivable
25,784

Inventories
23,559

Deferred income tax assets - current
860

Prepaids and other current assets
1,407

Property, plant and equipment
2,308

Goodwill
103,255

Intangible assets
724,374

Total assets acquired
885,054

 
 
Accounts payable
16,079

Accrued expenses
8,003

Deferred income tax liabilities - long term
107,799

Total liabilities assumed
131,881

Total purchase price
$
753,173

Pro Forma Information
The following table provides our unaudited pro forma revenues, net income and net income per basic and diluted common share had the results of Insight's operations been included in our operations commencing on April 1, 2013, based upon available information related to Insight's operations. This pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the Insight acquisition been consummated at the beginning of the period for which the pro forma information is presented, or of future results.

 
Year Ended March 31,
(In thousands, except per share data)
2015
 
2014
 
(Unaudited)
Revenues
$
783,217

 
$
767,897

Net income
$
86,844

 
$
82,762

 
 
 
 
Earnings per share:
 
 
 
Basic
$
1.66

 
$
1.60

 
 
 
 
Diluted
$
1.65

 
$
1.58

Hydralyte  
Business Acquisition [Line Items]  
Purchase Price Allocation
The following table summarizes our allocation of the assets acquired and liabilities assumed as of the April 30, 2014 acquisition date.

(In thousands)
April 30, 2014
 
 
Inventories
$
1,970

Property, plant and equipment, net
1,267

Goodwill
1,224

Intangible assets, net
73,580

Total assets acquired
78,041

 
 
Accrued expenses
38

Other long term liabilities
12

Total liabilities assumed
50

Net assets acquired
$
77,991

Care Pharma  
Business Acquisition [Line Items]  
Purchase Price Allocation
The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2013 acquisition date.
(In thousands)
July 1, 2013

 
 
Cash acquired
$
1,546

Accounts receivable
1,658

Inventories
2,465

Deferred income tax assets
283

Prepaids and other current assets
647

Property, plant and equipment
163

Goodwill
23,122

Intangible assets
31,502

Total assets acquired
61,386

 
 
Accounts payable
1,537

Accrued expenses
2,788

Other long term liabilities
300

Total liabilities assumed
4,625

 
 
Net assets acquired
$
56,761